湿性老年黄斑变性amd是欧洲和北美超过了50岁的人们的视觉减退的首要原因。
Wet AMD is the leading cause of visual loss in people over the age of 50 in Europe and North America.
Genetech公司研制的药物Lucentis被证明能够有效治疗湿性年龄相关性黄斑变性(亦称老年性黄斑变性)，这种眼病可以导致失明。
A drug called Lucentis, made by Genetech, has proved effective at treating the wet form of age-related macular degeneration, which can lead to blindness.
湿性老年性黄斑变性是老年性黄斑变性中最严重的一种类型，可在确诊后数月内出现中央视力丧失。
The most serious form of AMD, it can lead to loss of central vision within months of diagnosis.
目的研究湿性老年性黄斑变性（AMD）的B型超声特征。
Objective To study specific image features of wet-form AMD using B scan ultrasonography.
目的研究湿性老年性黄斑变性（AMD）的B型超声特征。
Objective To study specific image features of wet-form AMD using B scan ultrasonography.
应用推荐